Hong Kong – Norman Ng, Director of Patient Advocacy and Public Affairs at Healthcare Thinkers, recently shared a message of profound gratitude and encouragement following his attendance at the Hong Kong Cancer Fund’s 2025 Volunteer Appreciation Ceremony. Ng, a cancer survivor and the Convenor of the Hong Kong Lung Cancer Patient Concern Group, emphasized the critical role volunteers and dedicated medical professionals play in supporting individuals navigating cancer diagnoses and treatment. His remarks underscored the importance of compassionate care alongside medical intervention in improving patient outcomes and fostering a sense of community.
Speaking at the ceremony, Ng expressed deep appreciation for the Hong Kong Cancer Fund’s longstanding commitment to providing support services, particularly through its social work team. He highlighted that cancer patients require more than just medical treatment and medication; they need the companionship, understanding, and shared experiences that approach from a supportive community. This sentiment reflects a growing recognition within the healthcare landscape of the holistic needs of cancer patients, extending beyond the clinical setting.
The Power of Collaboration in Cancer Care
Ng’s message also extended heartfelt thanks to the medical professionals who volunteer their time and expertise to support cancer patients. He specifically acknowledged Dr. Lam Bing, Dr. Anita Lo, and Dr. Johnny, recognizing their dedication to providing continued care and warmth beyond the confines of the clinic. This collaborative spirit between healthcare providers and volunteer organizations is crucial in addressing the multifaceted challenges faced by individuals battling cancer. The importance of early detection and access to innovative treatments, such as those being explored with AI-assisted lung cancer screening, were also implicitly highlighted through Ng’s broader advocacy work, as reported by OncoDaily.
He also extended a special thank you to Iris, Head of Service at the Hong Kong Cancer Fund, for her leadership in building a platform that empowers the cancer community. Ng’s LinkedIn post, which detailed his experience at the ceremony, resonated with many, emphasizing the collective strength found in shared experiences and mutual support. He described the volunteers, healthcare workers, and patients as “glimmers of light” who, when united, create a “sun that illuminates each other.”
Advocacy for Lung Cancer Screening in Hong Kong
Ng’s commitment to improving cancer care extends beyond expressions of gratitude. As Convenor of the Hong Kong Lung Cancer Patient Concern Group, he has been a vocal advocate for comprehensive lung cancer screening programs in Hong Kong. He has urged the Hong Kong government to prioritize early detection through low-dose CT scans, citing the potential to dramatically improve survival rates. This advocacy aligns with his work promoting the implementation of AI-assisted lung cancer screening, as discussed at a roundtable meeting organized by the Cancer Strategy Concern Group and the DAB, according to OncoDaily. A pilot program funded by The Hong Kong Jockey Club’s Charities Trust, which Ng also supports, represents a significant step towards improving early detection rates, as noted in a recent post.
Ng has championed increased access to treatment options for patients with extensive-stage small cell lung cancer (ES-SCLC), expressing gratitude to the Greater China Cancer Foundation and CHIATAI TIANQING Pharmaceutical Group for launching a compassionate Named Patient Program, as detailed on OncoDaily. His dedication to patient advocacy extends to supporting initiatives that improve access to care and enhance the quality of life for those affected by cancer.
The Hong Kong Cancer Fund plays a vital role in this ecosystem, providing crucial support services and fostering a sense of community for patients and their families. Ng’s recognition of their work underscores the importance of collaborative efforts in tackling the challenges of cancer care.
As the landscape of cancer treatment continues to evolve, with advancements in AI-assisted screening and compassionate access programs, the dedication of individuals like Norman Ng and the tireless efforts of organizations like the Hong Kong Cancer Fund will remain essential in ensuring that patients receive the comprehensive care and support they deserve. The ongoing recruitment for the Senior Manager role within the Lung Cancer Screening Pilot Programme, which Ng enthusiastically supports, signals a continued commitment to improving early detection and saving lives in Hong Kong.
What comes next will likely involve continued advocacy for expanded screening programs and increased investment in innovative cancer treatments. The success of the current pilot program will be a key indicator of future policy decisions and resource allocation. We encourage readers to share their thoughts and experiences with cancer care in the comments below.
Disclaimer: This article provides informational content about health and medical topics. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider for any questions you may have regarding a medical condition.
